The Board of Directors of Chong Kun Dang Pharmaceutical Corp. has authorized a buyback plan on January 23, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
101,100 KRW | +0.50% | +1.92% | -22.77% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.77% | 936M | |
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- A185750 Stock
- News Chong Kun Dang Pharmaceutical Corp.
- Chong Kun Dang Pharmaceutical Corp. authorizes a Buyback Plan.